Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Shital Jibhe Article rating: 5.0

The markets on December 17, 2018 opened gap up. BSE Sensex is trading at 36,202.70, up by 239.77 points and the Nifty is trading at 10,858.75, up by 53.30 points. 

What is the right asset allocation for your retirement corpus?
What is the right asset allocation for your retirement corpus?

What is the right asset allocation for your retirement corpus?

Henil Shah Article rating: 5.0

Investors have to focus on asset allocation while dealing with retirement corpus. Generally, investors worry whether one must continue with the existing asset allocation or one must change it to suit the requirements at the time of retirement. Let’s find out.

Havells India to invest Rs. 1,500 crore in 5 years
Havells India to invest Rs. 1,500 crore in 5 years

Havells India to invest Rs. 1,500 crore in 5 years

Aakash Makhija Article rating: 4.3
Also, the company plans to invest in the expansion of its R&D facility in Bengaluru. The design studio and research facility with a focus on Internet of Things (IoT) applications hiring at least 100 engineers and researchers.
Glenmark Pharma soars 5 per cent on approval of skin ointment
Glenmark Pharma soars 5 per cent on approval of skin ointment

Glenmark Pharma soars 5 per cent on approval of skin ointment

Nidhi Jani Article rating: 5.0

Hydrocortisone Valerate Ointment is used in the treatment of skin disease like swelling, itching and redness. As per IQVIA, the market for the said medicine was approx US$11.1 million in the 12-month period ending October 2018 in the US market.

NTPC acquires Barauni Thermal Power Station
NTPC acquires Barauni Thermal Power Station

NTPC acquires Barauni Thermal Power Station

Apurva Joshi Article rating: 5.0

NTPC Limited acquired Barauni Thermal Power Station (720 MW) in District Begusarai, Bihar. The company acquired the power station from Bihar State Power Generation Company Limited (BSPGCL) effective from December 15, 2018.

Biocon: USFDA clears Telangana API facility
Biocon: USFDA clears Telangana API facility

Biocon: USFDA clears Telangana API facility

Gayathri Udyawar Article rating: 5.0

The biotech major's Active Pharmaceutical Ingredient (API) manufacturing facility located in Telangana was inspected by USFDA in the month of December. The inspection concluded without any observation.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 80.12 lakh contracts with a turnover of Rs. 4,80,578.85 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 80.12 lakh contracts with a turnover of Rs. 4,80,578.85 crore.

Index trend and stocks in action December 17, 2018
Index trend and stocks in action December 17, 2018

Index trend and stocks in action December 17, 2018

Karan Dsij Article rating: 5.0

Going ahead, the zone of 10,750-10,757 is likely to act as crucial support for the index. On the upside, immediate hurdle is placed around the level of 10,811. Stocks in news: Biocon, Reliance Industries, Wipro, NTPC, Cadila Healthcare, Datamatics Global Services, Infosys, Bharti Airtel, Future Consumer and Canara Bank.

Markets may open positive amid mixed cues from Asian peers
Markets may open positive amid mixed cues from Asian peers

Markets may open positive amid mixed cues from Asian peers

Karan Dsij Article rating: 5.0

Indian markets are expected to open with modest gains as cues from Asian peers are mixed. The SGX Nifty is currently trading at 10,858 level, up by 27 points.   


RSS
First27552756275727582760276227632764Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR